Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   

13

Number of overlapping holdings

56.5%

% of XDNA's 23 holdings also in GNOM

31.7%

% of GNOM's 41 holdings also in XDNA

Overlap by Weight
Sector Drift (XDNA minus GNOM)
Overlapping Holdings

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in XDNA
Weight
in GNOM
Overlap
INTELLIA THERAPEUTICS, INC. 8.7% 4.0% 4.0%
CRISPR THERAPEUTICS AG 15.1% 3.2% 3.2%
AGILENT TECHNOLOGIES INC 2.7% 3.8% 2.7%
BEAM THERAPEUTICS, INC. 13.7% 2.5% 2.5%
VERTEX PHARMACEUTICALS INC 1.5% 1.9% 1.5%

Position Highlights (Non-Overlapping Exposures)
XDNA Overweight Relative to GNOM
CRISPR THERAPEUTICS AG 11.9%
BEAM THERAPEUTICS, INC. 11.1%
THERMO FISHER SCIENTIFIC INC 9.5%
PRIME MEDICINE, INC. 5.9%
EDITAS MEDICINE, INC. 4.9%
INTELLIA THERAPEUTICS, INC. 4.7%
CARIBOU BIOSCIENCES, INC. 4.2%
VERVE THERAPEUTICS, INC. 3.9%
ABBVIE INC 3.8%
POSEIDA THERAPEUTICS, INC. 3.7%
XDNA Underweight Relative to GNOM
ENI SPA-SPONSORED ADR -7.2%
BIO-TECHNE CORPORATION -4.5%
NATERA INC -4.1%
MYRIAD GENETICS INC -3.8%
MODERNA, INC. -3.8%
SAREPTA THERAPEUTICS INC -3.8%
ALNYLAM PHARMACEUTICALS INC -3.7%
BIONTECH SE SPONSORED ADR -3.7%
LEGEND BIOTECH CORPORATION SPONSORED -3.4%
ARROWHEAD PHARMACEUTICALS, INC. -3.4%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY